Advanced in Neurotoxicity Syndromes

David Balayssac

Clermont-ferrand, FR 
Advanced in Neurotoxicity Syndromes
Clermont-ferrand, FR 
OverviewLocationsClinical Research

Overview

David Balayssac practices in Clermont-ferrand, France. Mr. Balayssac is rated as an Advanced expert by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Peripheral Neuropathy, Neuralgia, Neurotoxicity Syndromes, Acute Pain, and Endoscopy.

His clinical research consists of co-authoring 56 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Neurotoxicity Syndromes.

Gender
Male

Locations

Clermont-ferrand, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Evaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy: Observational and Transversal Study
Evaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy: Observational and Transversal Study
Enrollment Status: Completed
Publish Date: June 06, 2022
Intervention Type: Drug
Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response
Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response
Enrollment Status: Completed
Publish Date: May 04, 2022
Evaluation of the Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders: Monocentric Observational and Cross-sectional Study.
Evaluation of the Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders: Monocentric Observational and Cross-sectional Study.
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug
Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Neuropathies: Observational and Cross-sectional Study
Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Neuropathies: Observational and Cross-sectional Study
Enrollment Status: Completed
Publish Date: May 24, 2019
Intervention Type: Other
Evaluation of Pharmacy Students' Perception of Opioid / Opiate Dependence: Cross-sectional National Study
Evaluation of Pharmacy Students' Perception of Opioid / Opiate Dependence: Cross-sectional National Study
Enrollment Status: Completed
Publish Date: May 24, 2019
Intervention Type: Other
View 4 Less Clinical Trials

56 Total Publications

Preventing neuropathy and improving anti-cancer chemotherapy with a carbazole-based compound.
Preventing neuropathy and improving anti-cancer chemotherapy with a carbazole-based compound.
Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Balayssac's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile